CWC
Carolinas Wealth Consulting’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,562
| Closed | -$456K | – | 424 |
|
2025
Q1 | $456K | Buy |
3,562
+151
| +4% | +$19.3K | 0.1% | 111 |
|
2024
Q4 | $451K | Sell |
3,411
-48
| -1% | -$6.35K | 0.09% | 114 |
|
2024
Q3 | $503K | Buy |
3,459
+2
| +0.1% | +$291 | 0.09% | 109 |
|
2024
Q2 | $474K | Buy |
3,457
+1
| +0% | +$137 | 0.09% | 109 |
|
2024
Q1 | $474K | Sell |
3,456
-19
| -0.5% | -$2.61K | 0.09% | 104 |
|
2023
Q4 | $472K | Hold |
3,475
| – | – | 0.1% | 93 |
|
2023
Q3 | $395K | Sell |
3,475
-334
| -9% | -$38K | 0.1% | 96 |
|
2023
Q2 | $484K | Sell |
3,809
-517
| -12% | -$65.6K | 0.1% | 104 |
|
2023
Q1 | $559K | Buy |
4,326
+70
| +2% | +$9.04K | 0.12% | 93 |
|
2022
Q4 | $559K | Buy |
4,256
+951
| +29% | +$125K | 0.13% | 88 |
|
2022
Q3 | $387K | Buy |
3,305
+3
| +0.1% | +$351 | 0.1% | 106 |
|
2022
Q2 | $388K | Buy |
3,302
+1
| +0% | +$118 | 0.1% | 101 |
|
2022
Q1 | $430K | Buy |
3,301
+2
| +0.1% | +$261 | 0.1% | 99 |
|
2021
Q4 | $504K | Hold |
3,299
| – | – | 0.11% | 90 |
|
2021
Q3 | $533K | Sell |
3,299
-1,239
| -27% | -$200K | 0.12% | 82 |
|
2021
Q2 | $743K | Buy |
4,538
+1
| +0% | +$164 | 0.16% | 64 |
|
2021
Q1 | $683K | Buy |
4,537
+3
| +0.1% | +$452 | 0.17% | 67 |
|
2020
Q4 | $687K | Sell |
4,534
-11,205
| -71% | -$1.7M | 0.18% | 64 |
|
2020
Q3 | $2.13M | Sell |
15,739
-193
| -1% | -$26.1K | 0.72% | 29 |
|
2020
Q2 | $2.18M | Buy |
+15,932
| New | +$2.18M | 0.86% | 25 |
|